PRMT5 and colorectal carcinoma: In colorectal cancer (CRC), PRMT5-deposited H4R3me2s and H3R8me2s co-localize with EZH2-mediated H3K27me3 at the CDKN2B promoter, synergistically repressing transcription (Fig. 2C) [61].